May 07, 2020 / 12:15PM GMT
Presentation
May 07, 2020 / 12:15PM GMT
=====================
Corporate Participants
=====================
* Camilla Sylvest
Novo Nordisk A/S - Executive VP, Head of Commercial Strategy & Corporate Affairs and Member of the Management Board
* Karsten Munk Knudsen
Novo Nordisk A/S - Executive VP, CFO & Member of the Management Board
* Mads Krogsgaard Thomsen
Novo Nordisk A/S - Executive VP, Chief Science Officer & Member of the Management Board
=====================
Conference Call Participants
=====================
* Jiaxi Liu
* Keyur Parekh
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Michael Leuchten
UBS Investment Bank, Research Division - Co-Head of Pharmaceuticals Research of Equity Research
* Peter Verdult
Citigroup Inc, Research Division - MD
* Peter Sehested
Handelsbanken Capital Markets AB, Research Division - Research Analyst
* Richard Vosser
JP Morgan Chase & Co, Research Division - Senior Analyst
*
Novo Nordisk AS
(HAM:NOVA)
€
41.8
-0.20 (-0.48%)
Market Cap: 185.04 Bil
Enterprise Value: 201.74 Bil
PE Ratio: 11.60
PB Ratio: 6.95
GF Score: 81/100 Q1 2020 Novo Nordisk A/S Earnings Presentation Transcript
May 07, 2020 / 12:15PM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot